RU2018112710A - Способы размножения мезенхимальных стволовых клеток (MSC) для применения в трансплантации - Google Patents
Способы размножения мезенхимальных стволовых клеток (MSC) для применения в трансплантации Download PDFInfo
- Publication number
- RU2018112710A RU2018112710A RU2018112710A RU2018112710A RU2018112710A RU 2018112710 A RU2018112710 A RU 2018112710A RU 2018112710 A RU2018112710 A RU 2018112710A RU 2018112710 A RU2018112710 A RU 2018112710A RU 2018112710 A RU2018112710 A RU 2018112710A
- Authority
- RU
- Russia
- Prior art keywords
- apoptosis
- cells
- inducing agent
- stem cells
- mesenchymal stem
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims 15
- 210000002901 mesenchymal stem cell Anatomy 0.000 title claims 10
- 238000002054 transplantation Methods 0.000 title claims 2
- 230000006907 apoptotic process Effects 0.000 claims 14
- 210000004027 cell Anatomy 0.000 claims 13
- 239000003795 chemical substances by application Substances 0.000 claims 13
- 230000001939 inductive effect Effects 0.000 claims 13
- 238000011534 incubation Methods 0.000 claims 6
- 239000002609 medium Substances 0.000 claims 6
- 108060008682 Tumor Necrosis Factor Proteins 0.000 claims 4
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 claims 4
- 102100031988 Tumor necrosis factor ligand superfamily member 6 Human genes 0.000 claims 4
- 108050002568 Tumor necrosis factor ligand superfamily member 6 Proteins 0.000 claims 4
- 239000001963 growth medium Substances 0.000 claims 3
- 230000001902 propagating effect Effects 0.000 claims 3
- 102100024598 Tumor necrosis factor ligand superfamily member 10 Human genes 0.000 claims 2
- 101710097160 Tumor necrosis factor ligand superfamily member 10 Proteins 0.000 claims 2
- 238000012258 culturing Methods 0.000 claims 2
- 238000002955 isolation Methods 0.000 claims 2
- 102000004127 Cytokines Human genes 0.000 claims 1
- 108090000695 Cytokines Proteins 0.000 claims 1
- 102000015212 Fas Ligand Protein Human genes 0.000 claims 1
- 108010039471 Fas Ligand Protein Proteins 0.000 claims 1
- 206010054094 Tumour necrosis Diseases 0.000 claims 1
- 239000013543 active substance Substances 0.000 claims 1
- 210000000577 adipose tissue Anatomy 0.000 claims 1
- 239000003102 growth factor Substances 0.000 claims 1
- 239000005556 hormone Substances 0.000 claims 1
- 229940088597 hormone Drugs 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 239000000411 inducer Substances 0.000 claims 1
- 238000007443 liposuction Methods 0.000 claims 1
- 210000000056 organ Anatomy 0.000 claims 1
- 210000000130 stem cell Anatomy 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 claims 1
- 230000002792 vascular Effects 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0607—Non-embryonic pluripotent stem cells, e.g. MASC
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/25—Tumour necrosing factors [TNF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
- C12N2501/48—Regulators of apoptosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Physical Education & Sports Medicine (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Transplantation (AREA)
- Hospice & Palliative Care (AREA)
- Dermatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562222853P | 2015-09-24 | 2015-09-24 | |
| US62/222,853 | 2015-09-24 | ||
| PCT/IL2016/051053 WO2017051421A1 (en) | 2015-09-24 | 2016-09-22 | Methods for propagating mesenchymal stem cells (msc) for use in transplantation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2018112710A true RU2018112710A (ru) | 2019-10-24 |
Family
ID=57121465
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2018112710A RU2018112710A (ru) | 2015-09-24 | 2016-09-22 | Способы размножения мезенхимальных стволовых клеток (MSC) для применения в трансплантации |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US11578306B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3353286A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7011827B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20180050750A (cg-RX-API-DMAC7.html) |
| CN (1) | CN108138142A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2016327285A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2999140A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL258267B (cg-RX-API-DMAC7.html) |
| RU (1) | RU2018112710A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2017051421A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201604304D0 (en) * | 2016-03-14 | 2016-04-27 | Tigenix S A U | Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn's disease |
| WO2019086912A1 (en) * | 2017-11-06 | 2019-05-09 | King's College London | Therapeutic substances, their preparation and diagnostic procedure |
| KR20210008339A (ko) * | 2018-05-08 | 2021-01-21 | 셀렉트 바이오테라퓨틱스 리미티드 | 지방 유래 줄기 세포를 확장시키는 방법 |
| CN113943705B (zh) * | 2021-11-01 | 2023-09-19 | 北京大学口腔医学院 | 一种凋亡微囊泡及其制备方法和应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL68218A (en) | 1983-03-23 | 1985-12-31 | Univ Ramot | Compositions for cartilage repair comprising embryonal chondrocytes |
| US5486359A (en) | 1990-11-16 | 1996-01-23 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells |
| US5851832A (en) | 1991-07-08 | 1998-12-22 | Neurospheres, Ltd. | In vitro growth and proliferation of multipotent neural stem cells and their progeny |
| US5736396A (en) | 1995-01-24 | 1998-04-07 | Case Western Reserve University | Lineage-directed induction of human mesenchymal stem cell differentiation |
| EP0893493A3 (de) | 1997-07-21 | 2002-12-04 | Aventis Pharma Deutschland GmbH | Genetisch veränderte Zellen und deren Verwendung in der Prophylaxe oder Therapie von Erkrankungen |
| CA2653881C (en) * | 2006-05-31 | 2016-08-23 | Styx Llc | Methods of selecting stem cells and uses thereof |
| EP3043806A4 (en) * | 2013-09-11 | 2017-05-17 | University Of Southern California | A composition of stem cells having highly expressed fas ligand |
-
2016
- 2016-09-22 CA CA2999140A patent/CA2999140A1/en not_active Abandoned
- 2016-09-22 JP JP2018515293A patent/JP7011827B2/ja not_active Expired - Fee Related
- 2016-09-22 AU AU2016327285A patent/AU2016327285A1/en not_active Abandoned
- 2016-09-22 WO PCT/IL2016/051053 patent/WO2017051421A1/en not_active Ceased
- 2016-09-22 CN CN201680061134.1A patent/CN108138142A/zh active Pending
- 2016-09-22 US US15/762,956 patent/US11578306B2/en active Active
- 2016-09-22 EP EP16778893.4A patent/EP3353286A1/en not_active Withdrawn
- 2016-09-22 KR KR1020187011049A patent/KR20180050750A/ko not_active Withdrawn
- 2016-09-22 RU RU2018112710A patent/RU2018112710A/ru not_active Application Discontinuation
-
2018
- 2018-03-21 IL IL258267A patent/IL258267B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2999140A1 (en) | 2017-03-30 |
| JP7011827B2 (ja) | 2022-02-10 |
| IL258267B (en) | 2022-05-01 |
| WO2017051421A1 (en) | 2017-03-30 |
| US20180340144A1 (en) | 2018-11-29 |
| AU2016327285A1 (en) | 2018-04-12 |
| CN108138142A (zh) | 2018-06-08 |
| IL258267A (en) | 2018-05-31 |
| US11578306B2 (en) | 2023-02-14 |
| KR20180050750A (ko) | 2018-05-15 |
| EP3353286A1 (en) | 2018-08-01 |
| JP2018528782A (ja) | 2018-10-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Brennan et al. | Pre-clinical studies of bone regeneration with human bone marrow stromal cells and biphasic calcium phosphate | |
| CN103396990B (zh) | 一种制备间充质干细胞的方法 | |
| Kim et al. | Muscle regeneration by adipose tissue-derived adult stem cells attached to injectable PLGA spheres | |
| CN105076113B (zh) | 免疫细胞的冻存方法 | |
| RU2018112710A (ru) | Способы размножения мезенхимальных стволовых клеток (MSC) для применения в трансплантации | |
| Schiavo et al. | Endothelial properties of third-trimester amniotic fluid stem cells cultured in hypoxia | |
| RU2016151316A (ru) | Процессы культивирования в системе посевных ферментеров и способы их применения | |
| CN108451982A (zh) | 干细胞外泌体在促进血管化及血管新生中的应用 | |
| CN103320383B (zh) | 一种培养大鼠毛囊干细胞的培养基 | |
| CN102424813A (zh) | 一种高纯度小鼠骨骼肌卫星细胞的简易提取方法 | |
| CN103409365B (zh) | 一种短须裂腹鱼心脏细胞系的构建和超低温冷冻保存方法 | |
| RU2017107114A (ru) | Композиции стволовых клеток и способы получения стволовых клеток для применения в терапии | |
| JP2018528782A5 (cg-RX-API-DMAC7.html) | ||
| JP7244991B2 (ja) | 脂肪組織由来間質細胞を含む肝疾患治療剤およびその製造方法 | |
| Ren et al. | Hypoxia activates the PI3K/AKT/HIF-1α pathway to promote the anti-inflammatory effect of adipose mesenchymal stem cells | |
| CN105062953A (zh) | 三维诱导间充质干细胞转化为胰岛细胞的方法 | |
| CN102161981B (zh) | 一种重组蛋白联合诱导骨髓间充质干细胞转变为汗腺细胞的方法 | |
| CN104472474A (zh) | 一种人脂肪间充质干细胞冻存液 | |
| RU2272638C1 (ru) | Биотрансплантат, способ его получения и способ лечения хронического гепатита и цирроза печени (варианты) | |
| CN103215218B (zh) | 一种分离培养内皮克隆形成细胞的方法 | |
| RU2510276C1 (ru) | Способ получения клеток для заместительной клеточной терапии патологий печени | |
| CN102119936B (zh) | 制备利用人羊膜间充质细胞治疗缺血性脑损伤注射液的方法及其注射液 | |
| KR102121417B1 (ko) | Stat3 활성화제를 이용한 골격근세포 분화 유도용 조성물 및 이를 이용한 골격근세포 분화 유도 방법 | |
| CN104304233B (zh) | 一种冻存液及其用途和保藏脐带间充质干细胞的方法 | |
| CN106591225B (zh) | 3,3’-二吲哚甲烷提高脐带间质干细胞旁分泌和治疗皮肤损伤的用途 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA93 | Acknowledgement of application withdrawn (no request for examination) |
Effective date: 20190923 |